Daiwa Securities Group Inc. acquired a new position in shares of ICU Medical, Incorporated (NASDAQ:ICUI) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 16,449 shares of the medical instruments supplier’s stock, valued at approximately $3,553,000. Daiwa Securities Group Inc. owned 0.08% of ICU Medical as of its most recent filing with the SEC.
Several other large investors also recently bought and sold shares of ICUI. Janus Henderson Group PLC boosted its position in shares of ICU Medical by 17.6% during the 3rd quarter. Janus Henderson Group PLC now owns 1,684,094 shares of the medical instruments supplier’s stock worth $312,989,000 after purchasing an additional 251,793 shares during the period. Point72 Asset Management L.P. purchased a new position in shares of ICU Medical during the 3rd quarter worth approximately $22,246,000. Citadel Advisors LLC purchased a new position in shares of ICU Medical during the 3rd quarter worth approximately $18,135,000. Segall Bryant & Hamill LLC purchased a new position in shares of ICU Medical during the 3rd quarter worth approximately $12,589,000. Finally, Bank of Montreal Can boosted its position in shares of ICU Medical by 1,257.9% during the 4th quarter. Bank of Montreal Can now owns 21,020 shares of the medical instruments supplier’s stock worth $4,540,000 after purchasing an additional 19,472 shares during the period. 77.82% of the stock is owned by hedge funds and other institutional investors.
A number of research firms recently weighed in on ICUI. Zacks Investment Research raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $232.00 price objective for the company in a research report on Thursday, November 16th. KeyCorp began coverage on shares of ICU Medical in a research report on Tuesday, October 17th. They set a “sector weight” rating for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of $266.00.
In other ICU Medical news, Director Robert S. Swinney sold 1,000 shares of the stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $215.10, for a total transaction of $215,100.00. Following the sale, the director now directly owns 13,330 shares in the company, valued at approximately $2,867,283. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO Scott E. Lamb sold 23,624 shares of the stock in a transaction that occurred on Thursday, January 4th. The stock was sold at an average price of $220.00, for a total transaction of $5,197,280.00. Following the sale, the chief financial officer now owns 29,723 shares in the company, valued at $6,539,060. The disclosure for this sale can be found here. Insiders have sold a total of 27,348 shares of company stock valued at $6,014,640 in the last ninety days. 13.60% of the stock is currently owned by corporate insiders.
ICU Medical, Incorporated (NASDAQ:ICUI) opened at $220.60 on Wednesday. The company has a current ratio of 4.65, a quick ratio of 3.01 and a debt-to-equity ratio of 0.07. The firm has a market cap of $4,408.59, a P/E ratio of 85.88, a P/E/G ratio of 2.31 and a beta of 0.42. ICU Medical, Incorporated has a 1 year low of $142.01 and a 1 year high of $240.20.
COPYRIGHT VIOLATION NOTICE: “Daiwa Securities Group Inc. Purchases Shares of 16,449 ICU Medical, Incorporated (ICUI)” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/daiwa-securities-group-inc-purchases-shares-of-16449-icu-medical-incorporated-icui.html.
ICU Medical Profile
ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.